Selected research
Market Outlook & Growth Opportunities
Global Cholesterol Blood Test Market Outlook and Growth Opportunities 2026
Market perspective
The global Cholesterol Blood Test market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Cholesterol Blood Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Cholesterol Blood Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Cholesterol Blood Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Cholesterol Blood Test market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Cholesterol Blood Test market include cerascreen, LetsGet Checked, Everlywell, Thriva, MyHealth Checked, Labcorp OnDemand, Randox Health, Verisana and JR Biomedical, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Cholesterol Blood Test market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Cholesterol Blood Test and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Cholesterol Blood Test revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Cholesterol Blood Test market.
Cholesterol Blood Test Segment by Company
cerascreen
LetsGet Checked
Everlywell
Thriva
MyHealth Checked
Labcorp OnDemand
Randox Health
Verisana
JR Biomedical
empowerDX
Cholesterol Blood Test Segment by Type
Fingerstick Blood
Venous Blood
Cholesterol Blood Test Segment by Application
Domestic
Commercial
Cholesterol Blood Test Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Cholesterol Blood Test status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Cholesterol Blood Test key companies, revenue, market share, and recent developments.
3. To split the Cholesterol Blood Test breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Cholesterol Blood Test market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Cholesterol Blood Test significant trends, drivers, influence factors in global and regions.
6. To analyze Cholesterol Blood Test competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cholesterol Blood Test market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cholesterol Blood Test and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cholesterol Blood Test.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cholesterol Blood Test industry.
Chapter 3: Detailed analysis of Cholesterol Blood Test company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Cholesterol Blood Test in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Cholesterol Blood Test in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Fingerstick Blood
- Venous Blood
Applications
- Domestic
- Commercial
Companies covered
- cerascreen
- LetsGet Checked
- Everlywell
- Thriva
- MyHealth Checked
- Labcorp OnDemand
- Randox Health
- Verisana
- JR Biomedical
- empowerDX
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Cholesterol Blood Test Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Cholesterol Blood Test Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Cholesterol Blood Test Market Dynamics
- 2.1 Cholesterol Blood Test Industry Trends
- 2.2 Cholesterol Blood Test Industry Drivers
- 2.3 Cholesterol Blood Test Industry Opportunities and Challenges
- 2.4 Cholesterol Blood Test Industry Restraints
3 Cholesterol Blood Test Market by Company
- 3.1 Global Cholesterol Blood Test Company Revenue Ranking in 2025
- 3.2 Global Cholesterol Blood Test Revenue by Company (2021-2026)
- 3.3 Global Cholesterol Blood Test Company Ranking (2024-2026)
- 3.4 Global Cholesterol Blood Test Company Manufacturing Base and Headquarters
- 3.5 Global Cholesterol Blood Test Company Product Type and Application
- 3.6 Global Cholesterol Blood Test Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Cholesterol Blood Test Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Cholesterol Blood Test Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Cholesterol Blood Test Market by Type
- 4.1 Cholesterol Blood Test Type Introduction
- 4.1.1 Fingerstick Blood
- 4.1.2 Venous Blood
- 4.2 Global Cholesterol Blood Test Sales Value by Type
- 4.2.1 Global Cholesterol Blood Test Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Cholesterol Blood Test Sales Value by Type (2021-2032)
- 4.2.3 Global Cholesterol Blood Test Sales Value Share by Type (2021-2032)
5 Cholesterol Blood Test Market by Application
- 5.1 Cholesterol Blood Test Application Introduction
- 5.1.1 Domestic
- 5.1.2 Commercial
- 5.2 Global Cholesterol Blood Test Sales Value by Application
- 5.2.1 Global Cholesterol Blood Test Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Cholesterol Blood Test Sales Value by Application (2021-2032)
- 5.2.3 Global Cholesterol Blood Test Sales Value Share by Application (2021-2032)
6 Cholesterol Blood Test Regional Value Analysis
- 6.1 Global Cholesterol Blood Test Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Cholesterol Blood Test Sales Value by Region (2021-2032)
- 6.2.1 Global Cholesterol Blood Test Sales Value by Region: 2021-2026
- 6.2.2 Global Cholesterol Blood Test Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Cholesterol Blood Test Sales Value (2021-2032)
- 6.3.2 North America Cholesterol Blood Test Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Cholesterol Blood Test Sales Value (2021-2032)
- 6.4.2 Europe Cholesterol Blood Test Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Cholesterol Blood Test Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Cholesterol Blood Test Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Cholesterol Blood Test Sales Value (2021-2032)
- 6.6.2 South America Cholesterol Blood Test Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Cholesterol Blood Test Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Cholesterol Blood Test Sales Value Share by Country, 2025 VS 2032
7 Cholesterol Blood Test Country-level Value Analysis
- 7.1 Global Cholesterol Blood Test Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Cholesterol Blood Test Sales Value by Country (2021-2032)
- 7.2.1 Global Cholesterol Blood Test Sales Value by Country (2021-2026)
- 7.2.2 Global Cholesterol Blood Test Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Cholesterol Blood Test Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Cholesterol Blood Test Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Cholesterol Blood Test Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Cholesterol Blood Test Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Cholesterol Blood Test Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Cholesterol Blood Test Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Cholesterol Blood Test Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Cholesterol Blood Test Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Cholesterol Blood Test Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Cholesterol Blood Test Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Cholesterol Blood Test Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Cholesterol Blood Test Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Cholesterol Blood Test Sales Value Growth Rate (2021-2032)
- 7.7.2 France Cholesterol Blood Test Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Cholesterol Blood Test Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Cholesterol Blood Test Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Cholesterol Blood Test Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Cholesterol Blood Test Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Cholesterol Blood Test Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Cholesterol Blood Test Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Cholesterol Blood Test Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Cholesterol Blood Test Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Cholesterol Blood Test Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Cholesterol Blood Test Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Cholesterol Blood Test Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Cholesterol Blood Test Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Cholesterol Blood Test Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Cholesterol Blood Test Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Cholesterol Blood Test Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Cholesterol Blood Test Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Cholesterol Blood Test Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Cholesterol Blood Test Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Cholesterol Blood Test Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Cholesterol Blood Test Sales Value Growth Rate (2021-2032)
- 7.14.2 China Cholesterol Blood Test Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Cholesterol Blood Test Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Cholesterol Blood Test Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Cholesterol Blood Test Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Cholesterol Blood Test Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Cholesterol Blood Test Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Cholesterol Blood Test Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Cholesterol Blood Test Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Cholesterol Blood Test Sales Value Growth Rate (2021-2032)
- 7.17.2 India Cholesterol Blood Test Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Cholesterol Blood Test Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Cholesterol Blood Test Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Cholesterol Blood Test Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Cholesterol Blood Test Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Cholesterol Blood Test Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Cholesterol Blood Test Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Cholesterol Blood Test Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Cholesterol Blood Test Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Cholesterol Blood Test Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Cholesterol Blood Test Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Cholesterol Blood Test Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Cholesterol Blood Test Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Cholesterol Blood Test Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Cholesterol Blood Test Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Cholesterol Blood Test Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Cholesterol Blood Test Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Cholesterol Blood Test Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Cholesterol Blood Test Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Cholesterol Blood Test Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Cholesterol Blood Test Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Cholesterol Blood Test Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Cholesterol Blood Test Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Cholesterol Blood Test Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Cholesterol Blood Test Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Cholesterol Blood Test Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Cholesterol Blood Test Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Cholesterol Blood Test Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Cholesterol Blood Test Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Cholesterol Blood Test Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Cholesterol Blood Test Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Cholesterol Blood Test Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Cholesterol Blood Test Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Cholesterol Blood Test Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Cholesterol Blood Test Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Cholesterol Blood Test Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Cholesterol Blood Test Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Cholesterol Blood Test Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Cholesterol Blood Test Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Cholesterol Blood Test Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Cholesterol Blood Test Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 cerascreen
- 8.1.1 cerascreen Company Information
- 8.1.2 cerascreen Business Overview
- 8.1.3 cerascreen Cholesterol Blood Test Revenue and Gross Margin (2021-2026)
- 8.1.4 cerascreen Cholesterol Blood Test Product Portfolio
- 8.1.5 cerascreen Recent Developments
- 8.2 LetsGet Checked
- 8.2.1 LetsGet Checked Company Information
- 8.2.2 LetsGet Checked Business Overview
- 8.2.3 LetsGet Checked Cholesterol Blood Test Revenue and Gross Margin (2021-2026)
- 8.2.4 LetsGet Checked Cholesterol Blood Test Product Portfolio
- 8.2.5 LetsGet Checked Recent Developments
- 8.3 Everlywell
- 8.3.1 Everlywell Company Information
- 8.3.2 Everlywell Business Overview
- 8.3.3 Everlywell Cholesterol Blood Test Revenue and Gross Margin (2021-2026)
- 8.3.4 Everlywell Cholesterol Blood Test Product Portfolio
- 8.3.5 Everlywell Recent Developments
- 8.4 Thriva
- 8.4.1 Thriva Company Information
- 8.4.2 Thriva Business Overview
- 8.4.3 Thriva Cholesterol Blood Test Revenue and Gross Margin (2021-2026)
- 8.4.4 Thriva Cholesterol Blood Test Product Portfolio
- 8.4.5 Thriva Recent Developments
- 8.5 MyHealth Checked
- 8.5.1 MyHealth Checked Company Information
- 8.5.2 MyHealth Checked Business Overview
- 8.5.3 MyHealth Checked Cholesterol Blood Test Revenue and Gross Margin (2021-2026)
- 8.5.4 MyHealth Checked Cholesterol Blood Test Product Portfolio
- 8.5.5 MyHealth Checked Recent Developments
- 8.6 Labcorp OnDemand
- 8.6.1 Labcorp OnDemand Company Information
- 8.6.2 Labcorp OnDemand Business Overview
- 8.6.3 Labcorp OnDemand Cholesterol Blood Test Revenue and Gross Margin (2021-2026)
- 8.6.4 Labcorp OnDemand Cholesterol Blood Test Product Portfolio
- 8.6.5 Labcorp OnDemand Recent Developments
- 8.7 Randox Health
- 8.7.1 Randox Health Company Information
- 8.7.2 Randox Health Business Overview
- 8.7.3 Randox Health Cholesterol Blood Test Revenue and Gross Margin (2021-2026)
- 8.7.4 Randox Health Cholesterol Blood Test Product Portfolio
- 8.7.5 Randox Health Recent Developments
- 8.8 Verisana
- 8.8.1 Verisana Company Information
- 8.8.2 Verisana Business Overview
- 8.8.3 Verisana Cholesterol Blood Test Revenue and Gross Margin (2021-2026)
- 8.8.4 Verisana Cholesterol Blood Test Product Portfolio
- 8.8.5 Verisana Recent Developments
- 8.9 JR Biomedical
- 8.9.1 JR Biomedical Company Information
- 8.9.2 JR Biomedical Business Overview
- 8.9.3 JR Biomedical Cholesterol Blood Test Revenue and Gross Margin (2021-2026)
- 8.9.4 JR Biomedical Cholesterol Blood Test Product Portfolio
- 8.9.5 JR Biomedical Recent Developments
- 8.10 empowerDX
- 8.10.1 empowerDX Company Information
- 8.10.2 empowerDX Business Overview
- 8.10.3 empowerDX Cholesterol Blood Test Revenue and Gross Margin (2021-2026)
- 8.10.4 empowerDX Cholesterol Blood Test Product Portfolio
- 8.10.5 empowerDX Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst